The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.

The mean change from baseline for the two phosphate binders was −0.47 mmol/L (−1.47 mg/dL) and −0.73 mmol/L (−2.26 mg/dL) for colestilan and sevelamer, respectively: both reductions were highly significant changes from baseline (P < 0.001 in both cases).

also in 132,142 other papers

There was an overall trend for mean serum iPTH to increase.

also in 4,871 other papers